Cargando…

Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study

BACKGROUND: Accumulating evidence has demonstrated that an association between chronic pain and autoimmune diseases (AIDs). Nevertheless, it is unclear whether these associations refer to a causal relationship. We used a two-sample Mendelian randomization (MR) method to determine the causal relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yidan, Liu, Weizhi, Kong, Weishuang, Zhang, Shuangyi, Zhu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947645/
https://www.ncbi.nlm.nih.gov/pubmed/36845101
http://dx.doi.org/10.3389/fimmu.2023.1077088
_version_ 1784892603374764032
author Tang, Yidan
Liu, Weizhi
Kong, Weishuang
Zhang, Shuangyi
Zhu, Tao
author_facet Tang, Yidan
Liu, Weizhi
Kong, Weishuang
Zhang, Shuangyi
Zhu, Tao
author_sort Tang, Yidan
collection PubMed
description BACKGROUND: Accumulating evidence has demonstrated that an association between chronic pain and autoimmune diseases (AIDs). Nevertheless, it is unclear whether these associations refer to a causal relationship. We used a two-sample Mendelian randomization (MR) method to determine the causal relationship between chronic pain and AIDs. METHODS: We assessed genome-wide association study (GWAS) summary statistics for chronic pain [multisite chronic pain (MCP) and chronic widespread pain (CWP)], and eight common AIDs, namely, amyotrophic lateral sclerosis (ALS), celiac disease (CeD), inflammatory bowel disease (IBD), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus Erythematosus (SLE), type 1 diabetes (T1D) and psoriasis. Summary statistics data were from publicly available and relatively large-scale GWAS meta-analyses to date. The two-sample MR analyses were first performed to identify the causal effect of chronic pain on AIDs. The two-step MR and multivariable MR were used to determine if mediators (BMI and smoking) causally mediated any connection and to estimate the proportion of the association mediated by these factors combined. RESULTS: With the utilization of MR analysis, multisite chronic pain was associated with a higher risk of MS [odds ratio (OR) = 1.59, 95% confidence interval (CI) = 1.01-2.49, P = 0.044] and RA (OR = 1.72, 95% CI = 1.06-2.77, P = 0.028). However, multisite chronic pain had no significant effect on ALS (OR = 1.26, 95% CI = 0.92-1.71, P = 0.150), CeD (OR = 0.24, 95% CI = 0.02-3.64, P = 0.303), IBD (OR = 0.46, 95% CI = 0.09-2.27, P = 0.338), SLE (OR = 1.78, 95% CI = 0.82-3.88, P = 0.144), T1D (OR = 1.15, 95% CI = 0.65-2.02, P = 0.627) or Psoriasis (OR = 1.59, 95% CI = 0.22-11.26, P = 0.644). We also found positive causal effects of MCP on BMI and causal effects of BMI on MS and RA. Moreover, there were no causal connections between genetically predicted chronic widespread pain and the risk of most types of AIDs disease. CONCLUSION: Our MR analysis implied a causal relationship between MCP and MS/RA, and the effect of MCP on MS and RA may be partially mediated by BMI.
format Online
Article
Text
id pubmed-9947645
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99476452023-02-24 Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study Tang, Yidan Liu, Weizhi Kong, Weishuang Zhang, Shuangyi Zhu, Tao Front Immunol Immunology BACKGROUND: Accumulating evidence has demonstrated that an association between chronic pain and autoimmune diseases (AIDs). Nevertheless, it is unclear whether these associations refer to a causal relationship. We used a two-sample Mendelian randomization (MR) method to determine the causal relationship between chronic pain and AIDs. METHODS: We assessed genome-wide association study (GWAS) summary statistics for chronic pain [multisite chronic pain (MCP) and chronic widespread pain (CWP)], and eight common AIDs, namely, amyotrophic lateral sclerosis (ALS), celiac disease (CeD), inflammatory bowel disease (IBD), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus Erythematosus (SLE), type 1 diabetes (T1D) and psoriasis. Summary statistics data were from publicly available and relatively large-scale GWAS meta-analyses to date. The two-sample MR analyses were first performed to identify the causal effect of chronic pain on AIDs. The two-step MR and multivariable MR were used to determine if mediators (BMI and smoking) causally mediated any connection and to estimate the proportion of the association mediated by these factors combined. RESULTS: With the utilization of MR analysis, multisite chronic pain was associated with a higher risk of MS [odds ratio (OR) = 1.59, 95% confidence interval (CI) = 1.01-2.49, P = 0.044] and RA (OR = 1.72, 95% CI = 1.06-2.77, P = 0.028). However, multisite chronic pain had no significant effect on ALS (OR = 1.26, 95% CI = 0.92-1.71, P = 0.150), CeD (OR = 0.24, 95% CI = 0.02-3.64, P = 0.303), IBD (OR = 0.46, 95% CI = 0.09-2.27, P = 0.338), SLE (OR = 1.78, 95% CI = 0.82-3.88, P = 0.144), T1D (OR = 1.15, 95% CI = 0.65-2.02, P = 0.627) or Psoriasis (OR = 1.59, 95% CI = 0.22-11.26, P = 0.644). We also found positive causal effects of MCP on BMI and causal effects of BMI on MS and RA. Moreover, there were no causal connections between genetically predicted chronic widespread pain and the risk of most types of AIDs disease. CONCLUSION: Our MR analysis implied a causal relationship between MCP and MS/RA, and the effect of MCP on MS and RA may be partially mediated by BMI. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9947645/ /pubmed/36845101 http://dx.doi.org/10.3389/fimmu.2023.1077088 Text en Copyright © 2023 Tang, Liu, Kong, Zhang and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Tang, Yidan
Liu, Weizhi
Kong, Weishuang
Zhang, Shuangyi
Zhu, Tao
Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title_full Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title_fullStr Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title_full_unstemmed Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title_short Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
title_sort multisite chronic pain and the risk of autoimmune diseases: a mendelian randomization study
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947645/
https://www.ncbi.nlm.nih.gov/pubmed/36845101
http://dx.doi.org/10.3389/fimmu.2023.1077088
work_keys_str_mv AT tangyidan multisitechronicpainandtheriskofautoimmunediseasesamendelianrandomizationstudy
AT liuweizhi multisitechronicpainandtheriskofautoimmunediseasesamendelianrandomizationstudy
AT kongweishuang multisitechronicpainandtheriskofautoimmunediseasesamendelianrandomizationstudy
AT zhangshuangyi multisitechronicpainandtheriskofautoimmunediseasesamendelianrandomizationstudy
AT zhutao multisitechronicpainandtheriskofautoimmunediseasesamendelianrandomizationstudy